DE69739002D1 - Eine Kosmetische Zubereitung die Antagonisten des Neuropeptid-Y-Rezeptors enthaltet - Google Patents

Eine Kosmetische Zubereitung die Antagonisten des Neuropeptid-Y-Rezeptors enthaltet

Info

Publication number
DE69739002D1
DE69739002D1 DE69739002T DE69739002T DE69739002D1 DE 69739002 D1 DE69739002 D1 DE 69739002D1 DE 69739002 T DE69739002 T DE 69739002T DE 69739002 T DE69739002 T DE 69739002T DE 69739002 D1 DE69739002 D1 DE 69739002D1
Authority
DE
Germany
Prior art keywords
neuropeptide
antagonists
receptor
preparation containing
cosmetic preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69739002T
Other languages
English (en)
Inventor
Elisabeth Blanc-Ferras
Francoise Bono
Bernard Breda
Jean Courregelongue
Catherine Ducasse
Remy Mounier
Raymond Paul
Jean-Marie Pereillo
Michel Sabadie
Gal Claudine Serradeil-Le
Pol Vilain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Application granted granted Critical
Publication of DE69739002D1 publication Critical patent/DE69739002D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P11/00—Preparation of sulfur-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26—Ketones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00—Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
    • C09K2323/06—Substrate layer characterised by chemical composition
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/10—Bacillus licheniformis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69739002T 1996-10-23 1997-01-23 Eine Kosmetische Zubereitung die Antagonisten des Neuropeptid-Y-Rezeptors enthaltet Expired - Lifetime DE69739002D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612916A FR2754709B1 (fr) 1996-10-23 1996-10-23 Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition

Publications (1)

Publication Number Publication Date
DE69739002D1 true DE69739002D1 (de) 2008-10-30

Family

ID=9496938

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69739002T Expired - Lifetime DE69739002D1 (de) 1996-10-23 1997-01-23 Eine Kosmetische Zubereitung die Antagonisten des Neuropeptid-Y-Rezeptors enthaltet
DE69718409T Expired - Lifetime DE69718409T2 (de) 1996-10-23 1997-01-23 Neuropeptid Y Rezeptor Antagonisten enthaltende kosmetische Zusammensetzung
DE69739079T Expired - Lifetime DE69739079D1 (de) 1996-10-23 1997-01-23 Eine kosmetische Zubereitung die Antagonisten des Neuropeptide-Y-Rezeptors enthält

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE69718409T Expired - Lifetime DE69718409T2 (de) 1996-10-23 1997-01-23 Neuropeptid Y Rezeptor Antagonisten enthaltende kosmetische Zusammensetzung
DE69739079T Expired - Lifetime DE69739079D1 (de) 1996-10-23 1997-01-23 Eine kosmetische Zubereitung die Antagonisten des Neuropeptide-Y-Rezeptors enthält

Country Status (23)

Country Link
US (3) US5827853A (de)
EP (3) EP0838217B1 (de)
JP (1) JP3411463B2 (de)
KR (1) KR100240143B1 (de)
CN (1) CN1214780C (de)
AR (1) AR005583A1 (de)
AT (3) ATE230974T1 (de)
AU (1) AU705046B2 (de)
BR (1) BR9700835A (de)
CA (1) CA2196096C (de)
CO (1) CO4780017A1 (de)
DE (3) DE69739002D1 (de)
ES (3) ES2313914T3 (de)
FR (1) FR2754709B1 (de)
HK (1) HK1008981A1 (de)
HU (1) HU222663B1 (de)
IL (1) IL120092A (de)
MX (1) MX9700822A (de)
MY (1) MY117993A (de)
PE (1) PE799A1 (de)
PT (2) PT1093803E (de)
SI (3) SI0838217T1 (de)
TW (1) TW434024B (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
US8466109B2 (en) * 1998-10-05 2013-06-18 Laboratoires Expanscience Cosmetic method for preventing and/or treating skin stretchmarks, and use in dermatology
FR2787712B1 (fr) * 1998-12-24 2002-08-30 Sanofi Sa Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique
US6375948B1 (en) 1999-07-12 2002-04-23 Kao Corporation Treating method for suppressing hair growth
FR2800610B1 (fr) * 1999-11-05 2001-12-28 Sanofi Synthelabo Composition cosmetique amincissante contenant une substance inducteur de la production d'il-6
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
EP1337257A4 (de) * 2000-10-03 2004-04-07 Univ California Verwendung von neuropeptid-y-antagonisten bei der behandlung des alkoholismus
US7069026B2 (en) * 2001-06-28 2006-06-27 Nokia Corporation Geographic area assisted system selection for mobile stations
WO2003009854A1 (en) * 2001-07-20 2003-02-06 Lonza Ag Lipid lowering composition comprising carnitine and phytosterol
EP1542719A4 (de) 2001-12-05 2006-06-21 Baylor College Medicine Verfahren und zusammensetzungen zur steuerung der knochenbildung über modulation des sympathikotonus
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
FR2853541B1 (fr) * 2003-04-09 2008-07-04 Oreal Composition cosmetique stable contenant un glyceride d'acides gras, un alcool et un emulsionnant silicone particulier
WO2004098591A2 (en) 2003-05-05 2004-11-18 Probiodrug Ag Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
DE10340417C5 (de) * 2003-09-02 2011-05-05 Sebapharma Gmbh & Co. Kg Kosmetische oder dermatologische Zubereitung mit Phytosterolen in Form einer W/O-Emulsion
EP1680120A2 (de) 2003-11-03 2006-07-19 Probiodrug AG Zusammenstellungen zur behandlung von neuronalen erkrankungen
CN1918131B (zh) 2004-02-05 2011-05-04 前体生物药物股份公司 谷氨酰胺酰基环化酶抑制剂
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ATE480301T1 (de) * 2004-06-15 2010-09-15 Boots Co Plc Haarpflegezusammensetzungen und verfahren
FR2871688B1 (fr) 2004-06-16 2008-05-16 Oreal Procede pour favoriser la penetration d'un actif et composition permettant sa mise en oeuvre
EP1877076A4 (de) * 2005-04-15 2012-02-01 Regenertech Pty Ltd Verwendung von neuropeptid y (npy) sowie von agonisten und antagonisten davon zur geweberegeneration
AU2006255097B2 (en) * 2005-06-06 2012-02-09 Georgetown University Compositions and methods for lipo modeling
JP4960960B2 (ja) * 2005-06-24 2012-06-27 マルコ ブランデスティーニ 衝撃による硬度測定装置
FR2895239B1 (fr) * 2005-12-22 2008-05-30 Oreal Utilisation d'un antagoniste du neuropeptide y pour le soin des levres endommagees ou sensibles
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
SI2091948T1 (sl) 2006-11-30 2012-07-31 Probiodrug Ag Novi inhibitorji glutaminil ciklaze
EP1970051A1 (de) * 2007-03-14 2008-09-17 Merz Pharma GmbH & Co.KGaA Verwendung einer wässrigen Mikroemulsion zur Herstellung einer Formulierung zur Behandlung von Adipositas-Erkrankungen
EP2481408A3 (de) 2007-03-01 2013-01-09 Probiodrug AG Neue Verwendung von Inhibitoren der Glutaminyl Cyclase
DK2142514T3 (da) 2007-04-18 2015-03-23 Probiodrug Ag Thioureaderivater som glutaminylcyclase-inhibitorer
GB0719542D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Use of cocoa extract
GB0719545D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Novel use of cocoa extract
GB0719544D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Cocoa extract and use thereof
WO2008157635A2 (en) * 2007-06-19 2008-12-24 Kythera Biopharmaceuticals, Inc. Synthetic bile acid composition, method, and preparation
US20080318870A1 (en) * 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
JOP20180077A1 (ar) * 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
US20090263518A1 (en) 2008-04-17 2009-10-22 Barry Callebaut Ag Composition and Uses Thereof
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
US20100233301A1 (en) * 2009-03-11 2010-09-16 Jing Cheng Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same
AU2010294214B2 (en) 2009-09-11 2015-05-07 Vivoryon Therapeutics N.V. Heterocylcic derivatives as inhibitors of glutaminyl cyclase
FR2953716B1 (fr) 2009-12-16 2015-03-27 Oreal Kit de formulation d'un produit cosmetique
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
AU2011226074B2 (en) 2010-03-10 2015-01-22 Vivoryon Therapeutics N.V. Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
EP2560953B1 (de) 2010-04-21 2016-01-06 Probiodrug AG Hemmer der glutaminylzyklase
WO2012021133A1 (en) 2010-08-12 2012-02-16 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
FR2967573B1 (fr) 2010-11-23 2012-11-09 Rhodia Poliamida E Especialidades Ltda Kit cosmetique et utilisation pour ameliorer l'aspect de la peau
WO2012112940A1 (en) 2011-02-18 2012-08-23 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
JP6050264B2 (ja) 2011-03-16 2016-12-21 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
NZ620040A (en) 2011-08-23 2016-06-24 Kythera Biopharmaceuticals Inc Formulations of deoxycholic acid and salts thereof
RS53419B (en) 2011-08-23 2014-12-31 Kythera Biopharmaceuticals, Inc. FORMULATIONS OF DEOXYCHOLINIC ACID AND ITS SALTS
US10272121B2 (en) 2011-10-25 2019-04-30 Arch Personal Care Product, Lp Composition containing an extract of a sequential or simultaneous fermentation
JP6300641B2 (ja) * 2014-05-30 2018-03-28 ワミレスコスメティックス株式会社 皮膚バリア機能改善効果を有する放線菌培養物
CA3003746A1 (en) 2015-11-04 2017-05-11 Kythera Biopharmaceuticals, Inc. Treatments of accumulated fat with deoxycholic acid and salts thereof
JP6938860B2 (ja) * 2016-06-13 2021-09-22 株式会社リコー 形状支持用液体、及び立体造形物の製造方法
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979511A (en) 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
DE2603407A1 (de) 1976-01-29 1977-08-04 Wmf Wuerttemberg Metallwaren Wasserkessel
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US4337260A (en) 1981-09-10 1982-06-29 Yoshitomi Pharmaceutical Industries, Ltd. Imidazopyridine-spiro-piperidine compounds
JPS59192086A (ja) * 1983-04-15 1984-10-31 Mitsui Toatsu Chem Inc バチルス・リケニホルミスｍｎ００１
GB2138023A (en) * 1983-03-29 1984-10-17 Mitsui Toatsu Chemicals Bacillus licheniformis used in animal feeds
DE3410033A1 (de) 1984-03-19 1985-09-26 Alfred Teves Gmbh, 6000 Frankfurt Vorrichtung zur hydraulischen unterstuetzung der lenkkraft
US5128332A (en) * 1984-10-23 1992-07-07 Perstorp Ab Method of treating cardiovascular diseases using inositoltrisphosphate
GB2167408B (en) 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
JPS61155317A (ja) * 1984-12-28 1986-07-15 Lion Corp 口腔用組成物
DE3545986A1 (de) * 1985-12-23 1987-06-25 Franz Sauter Elektronisch gesteuertes musikinstrument
DE3790919T1 (de) * 1987-02-24 1989-03-23 Inst Mikrobiologii Virusologii Arzneimittel zur prophylaxe und behandlung von gastrointerfinalen erkrankungen des landwirtschaftsviehs
DE3811193A1 (de) 1988-04-01 1989-10-19 Boehringer Ingelheim Kg Neue peptide, verfahren zu ihrer herstellung und diese peptide enthaltende pharmazeutische zusammensetzungen
US5328899A (en) 1988-07-15 1994-07-12 The Salk Institute For Biological Studies NPY peptide analogs
EP0356399A3 (de) * 1988-08-26 1991-03-20 Sandoz Ag Substituierte 4-Azatricyclo (22.3.1.04.9) octacos-18-en-Derivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen
ZA896374B (en) 1988-08-26 1990-05-30 Merrell Dow Pharma Neuropeptide y antagonists
US5116605A (en) * 1989-03-09 1992-05-26 Alt John P Composition and skin treatment method therewith for mitigating acne and male-pattern baldness
DE59006842D1 (de) 1990-03-30 1994-09-22 Heumann Pharma Gmbh & Co Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung.
SE9002278L (sv) 1990-06-28 1991-12-29 Perstorp Ab Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
SE467340B (sv) * 1990-07-04 1992-07-06 Perstorp Ab Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist
FR2669537B1 (fr) * 1990-11-28 1993-02-19 Oreal Composition amincissante a base d'alpha-2-bloqueurs.
TW263508B (de) 1991-02-12 1995-11-21 Pfizer
WO1993012139A1 (en) 1991-12-19 1993-06-24 Garvan Institute Of Medical Research A novel molecule which inhibits neuropeptide tyrosine biological function
GB9213215D0 (en) 1992-06-20 1992-08-05 Wellcome Found Peptides
DE4326465A1 (de) 1993-01-20 1995-02-09 Thomae Gmbh Dr K Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2701480B1 (fr) 1993-02-15 1995-05-24 Sanofi Elf Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant.
DE4311756A1 (de) 1993-04-08 1994-10-13 Thomae Gmbh Dr K Modifizierte Peptide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP0707490A1 (de) * 1993-06-18 1996-04-24 University Of Cincinnati Antagonisten und agonisten des neuropeptid y
JPH07258068A (ja) * 1994-03-18 1995-10-09 Kao Corp 浴用剤組成物
JP3447809B2 (ja) * 1994-07-12 2003-09-16 花王株式会社 浴用剤
EP0705807B1 (de) * 1994-10-06 1999-09-01 Susumu Hibino Bakterielle Mittel zur Landwirtschaftlichen Verwendung
US6562862B1 (en) 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
EP0716854A3 (de) 1994-10-20 1996-08-28 Lilly Co Eli Zusammensetzungen zur Inhibierung von Neuropeptid Y
BR9509610A (pt) * 1994-11-07 1997-10-28 Pfizer Ligandos específicos de neuropeptideo Y1
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
US5621079A (en) * 1995-02-03 1997-04-15 Merck & Co., Inc. Neuropeptide Y receptor
US5536499A (en) * 1995-02-24 1996-07-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for reducing or preventing signs of cellulite
US5552411A (en) 1995-05-26 1996-09-03 Warner-Lambert Company Sulfonylquinolines as central nervous system and cardiovascular agents
US5554621A (en) 1995-06-07 1996-09-10 Bristol-Myers Squibb Company Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
US5552148A (en) * 1995-06-07 1996-09-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Petroleum jelly with inositol phosphates
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
FR2787712B1 (fr) * 1998-12-24 2002-08-30 Sanofi Sa Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique
FR2788434B1 (fr) * 1999-01-15 2001-05-11 Oreal Utilisation d'au moins un extrait d'au moins une bacterie filamenteuse non photosynthetique en tant qu'agent amincissant

Also Published As

Publication number Publication date
JP3411463B2 (ja) 2003-06-03
US6114336A (en) 2000-09-05
US5827853A (en) 1998-10-27
ATE412399T1 (de) 2008-11-15
ES2191154T3 (es) 2003-09-01
EP1093803B1 (de) 2008-09-17
ES2316403T3 (es) 2009-04-16
CN1214780C (zh) 2005-08-17
JPH10120551A (ja) 1998-05-12
MX9700822A (es) 1998-04-30
ATE408396T1 (de) 2008-10-15
EP0838217A3 (de) 1998-10-14
US6313128B1 (en) 2001-11-06
DE69718409T2 (de) 2003-11-13
SI0838217T1 (en) 2003-08-31
HUP9700410A2 (hu) 1998-07-28
FR2754709A1 (fr) 1998-04-24
MY117993A (en) 2004-08-30
HU9700410D0 (en) 1997-03-28
SI1093803T1 (sl) 2009-02-28
KR19980032063A (ko) 1998-07-25
BR9700835A (pt) 1998-07-07
HK1008981A1 (en) 1999-05-21
KR100240143B1 (ko) 2000-02-01
TW434024B (en) 2001-05-16
AR005583A1 (es) 1999-06-23
EP0838217B1 (de) 2003-01-15
EP1093803A2 (de) 2001-04-25
IL120092A (en) 2001-08-08
CA2196096C (en) 2001-10-23
AU705046B2 (en) 1999-05-13
CA2196096A1 (en) 1998-04-24
DE69739079D1 (de) 2008-12-11
EP1093803A3 (de) 2004-03-31
EP1132463B1 (de) 2008-10-29
HUP9700410A3 (en) 1999-07-28
FR2754709B1 (fr) 1999-03-05
PE799A1 (es) 1999-04-08
SI1132463T1 (sl) 2009-04-30
EP1132463A2 (de) 2001-09-12
DE69718409D1 (de) 2003-02-20
PT1132463E (pt) 2009-01-23
CO4780017A1 (es) 1999-05-26
CN1180519A (zh) 1998-05-06
ES2313914T3 (es) 2009-03-16
IL120092A0 (en) 1997-04-15
PT1093803E (pt) 2008-12-26
ATE230974T1 (de) 2003-02-15
AU1251597A (en) 1998-05-07
HU222663B1 (hu) 2003-09-29
EP0838217A2 (de) 1998-04-29
EP1132463A3 (de) 2004-03-24

Similar Documents

Publication Publication Date Title
ATE408396T1 (de) Eine kosmetische zubereitung die antagonisten des neuropeptid-y-rezeptors enthaltet
DE69207351D1 (de) Fibrinogen-Rezeptor-Antagoniste
DE69316725T2 (de) Brausekopf
DE69824350D1 (de) Kosmetische Zusammensetzung zur Bleichung der Haut und Inhibitor der Melaninbildung, der eine solche Kosmetische Zusammensetzung enthält
DE69817564D1 (de) Kosmetische zusammensetzung
FR2732706B1 (fr) Garde-corps d'echafaudage
DE69834091D1 (de) Kosmetische Zubereitung
DE69720747D1 (de) Kosmetische zusammensetzung
FR2785155B3 (fr) Structure d'element decoratif pour cheveux
NO179550C (no) Tachykinin reseptorantagonister
IS4597A (is) Ný lyfjafræðileg notkun AII-viðtaka mótlyfja
MC2312A1 (fr) Antagonistes de la bombesine
DE69715032D1 (de) Kosmetische antitraspirant zusammensetzung
DK94492A (da) Blandehoved
DZ2386A1 (fr) Forme microparticulaire d'un dérivé de tétrahydropyridine
KR970019393U (ko) 브이씨알 헤드의 로타리트랜스포머 연결구조
FR2756310B1 (fr) Montant auxiliaire d'echafaudage
FR2748177B1 (fr) Tete mixte d'impression-lecture
FR2761390B1 (fr) Element d'echafaudage
FR2761059B1 (fr) Composition pour bouton d'allumettes
KR940008460U (ko) 브이씨알용 헤드 드럼의 상부드럼 조립구조
LV10425A (lv) Fibrinogena receptoru antagonisti
KR940022022U (ko) 약용샤워헤드
UA25439A (uk) Змішувач для в'язких матеріалів
ES1018383Y (es) "gorra"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition